Get started
Author

Martin Doelberg

Observed names: Doelberg, M, M Doelberg, M. Doelberg
OpenAlex ID: A5018226650
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
2013 · J Gerry Coghlan, Christopher P Denton, et al. · Annals of the Rheumatic Diseases · 849
PDF
Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5
2001 · Olivier Langeron, Martin Doelberg, et al. · Anesthesia & Analgesia · 226
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
2021 · Kelly M. Chin, Olivier Sitbon, et al. · Journal of the American College of Cardiology · 184
PDF
Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury
2003 · Thomas A. Neff, Martin Doelberg, et al. · Anesthesia & Analgesia · 175
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
2018 · J. Gerry Coghlan, Matthias Wolf, et al. · European Respiratory Journal · 117
PDF
Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
2020 · Yasmina Bauer, Simon de Bernard, et al. · European Respiratory Journal · 84
PDF
Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study
2009 · Ekkehard Gruenig, Evangelos Michelakis, et al. · The Journal of Clinical Pharmacology · 64
PDF
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
2014 · Scott H Visovatti, Oliver Distler, et al. · Arthritis Research & Therapy · 51
PDF
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort
2017 · Carina Mihai, Milos Antic, et al. · Annals of the Rheumatic Diseases · 27
Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of the Randomized Controlled TRITON Study
2020 · K.M. Chin, O. Sitbon, et al. · American Journal of Respiratory and Critical Care Medicine · 24
OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study
2013 · C.P. Denton, J.G. Coghlan, et al. · Annals of the Rheumatic Diseases · 14
Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study
2020 · N Galie, O Sitbon, et al. · European Heart Journal · 3
Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON
2020 · Olivier Sitbon, Nazzareno Galiè, et al. · European Respiratory Journal · 2
An Evidence-Based Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT Study
2012 · Vallerie McLaughlin, Gerry Coghlan, et al. · CHEST Journal · 2
Reply
2022 · Kelly M. Chin, Martin Doelberg, et al. · Journal of the American College of Cardiology · 1
Initial Triple Oral Therapy in Pulmonary Arterial Hypertension (PAH): Extended Long-Term Outcome Data from TRITON
2021 · V. McLaughlin, K. Chin, et al. · The Journal of Heart and Lung Transplantation · 1
PDF
OP0034 Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the detect cohort
2017 · C Mihai, M Antic, et al. · Annals of the Rheumatic Diseases · 1
PDF
S94 Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON
2021 · L Howard, O Sitbon, et al. · Thorax
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis after negative right heart catheterisation
2018 · G Coghlan, M Wolf, et al. · Pneumologie
FRI0397 Baseline characteristics of systemic sclerosis patients with borderline mean pulmonary artery pressure: post-hoc analysis from the detect study
2013 · D. Khanna, O. Distler, et al. · Annals of the Rheumatic Diseases
Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven®) at repetitive high dose levels in patients with severe cranio-cerebral trauma
2001 · ThA Neff, C Jungheinrich, et al. · Critical Care
PDF
Works count: 22
Citation count: 1,825
H-index: 11
I10-index: 11
Year
Topic
Type